In a female patient with acute psychosis due to HIV-associated neurocognitive disorder and dementia who has been started on donepezil (Aricept) 5 mg at bedtime, what additional therapeutic recommendations are appropriate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Management of Acute Psychosis in HIV-Associated Neurocognitive Disorder

Add an antipsychotic medication immediately—risperidone is the first-line choice, starting at 0.25-0.5 mg daily and titrating to the minimum effective dose (typically 0.5-2 mg/day), while continuing the donepezil. 1

Antipsychotic Treatment Approach

The APA guidelines specifically address psychosis in dementia and recommend antipsychotics when symptoms are severe, dangerous, or cause significant distress 1. For your patient with acute psychosis:

Starting Antipsychotic Therapy

  • Initiate risperidone at 0.25-0.5 mg once daily (lower end for elderly or frail patients)
  • Titrate slowly to minimum effective dose over 1-2 weeks
  • Target dose typically 0.5-2 mg/day for psychosis in dementia 2
  • Critical: Discuss risks versus benefits with patient (if feasible) and family/surrogate decision maker before starting 1

Key Risks to Discuss

Antipsychotics in dementia carry:

  • Increased mortality risk
  • Cerebrovascular events
  • Extrapyramidal symptoms
  • Sedation and falls
  • Small treatment effect sizes in clinical trials 1

Monitoring and Reassessment

Use a quantitative measure to track response 1:

  • Assess response at 2 weeks and 4 weeks
  • If no clinically significant response after 4 weeks at adequate dose, taper and discontinue the antipsychotic 1
  • Monitor for side effects at each visit; if significant side effects occur, reassess risk-benefit and consider tapering 1

Donepezil Considerations

Your current donepezil 5 mg is appropriate 3:

  • Can increase to 10 mg after 4-6 weeks if tolerated and additional benefit needed
  • Evidence suggests donepezil may have modest benefit for psychotic symptoms when added to antipsychotics in dementia 4
  • Continue donepezil while managing acute psychosis with antipsychotic

HIV-Specific Considerations

Rule out active HIV-related brain injury 5:

  • Ensure HIV viral load is suppressed on current ART
  • Check CSF HIV RNA if neurological symptoms are progressive—CSF viral escape can cause acute psychosis and requires ART adjustment 5
  • Consider CD8 encephalitis if symptoms are severe with brain swelling (requires corticosteroids) 5
  • Verify no opportunistic CNS infections

Non-Pharmacological Interventions

Before or concurrent with antipsychotic initiation 1:

  • Environmental modifications (reduce stimulation, maintain routine)
  • Address pain, constipation, urinary retention
  • Optimize sleep hygiene
  • Caregiver education and support

Treatment Duration

If patient responds to antipsychotic 1:

  • Attempt taper after 3-4 months of stability
  • Discuss tapering plan with patient/family, weighing ongoing benefits versus cumulative risks
  • Many patients can successfully discontinue after acute episode resolves

Common Pitfalls to Avoid

  • Don't use antipsychotics for mild behavioral symptoms—reserve for severe, dangerous, or highly distressing psychosis 1
  • Don't continue antipsychotic indefinitely without reassessment—attempt taper when stable 1
  • Don't assume cognitive impairment alone requires antipsychotic—only treat if psychosis or severe agitation present
  • Don't miss CSF viral escape in HIV patients with acute neuropsychiatric changes 5

References

Related Questions

What is the recommended starting dose and titration schedule of fluoxetine for an elderly patient with dementia?
What is the best psychotropic management for a 63-year-old male nursing home resident with alcohol-induced dementia who is currently taking risperidone 0.5 mg twice daily and trazodone 25 mg at bedtime, and who continues to have dementia-related psychosis, wandering, hostile aggression, and insomnia?
What is the appropriate initial dose and dosing frequency of antipsychotic medication for a 66‑year‑old patient with unspecified dementia who is experiencing false beliefs (psychotic symptoms)?
What is the appropriate first-line medication for a 69-year-old patient without a dementia diagnosis who presents with depressive symptoms?
What is the appropriate starting dose and titration schedule of risperidone (Risperdal) for a 10-year-old child weighing 32 kg?
What is the differential diagnosis for a 14-year-old male who experiences elbow locking when the joint is held in flexion for a prolonged period?
In a 53‑year‑old man with combined systolic‑diastolic heart failure, persistent erythrocytosis (hemoglobin 18.3 g/dL, hematocrit 54 %, RBC 5.97 ×10^12/L), history of pulmonary sarcoidosis in remission, normal cardiac imaging and electrophysiology, and a benign 0.62‑mm gallbladder polyp, how should I proceed with management given that the hematologist declined to treat the erythrocytosis?
What is polychromasia, what does it indicate, and which laboratory tests should be ordered to evaluate it?
In a 30‑year‑old male, 5 ft 11 in, 130 lb, with a decade of moderate alcohol use (up to 3 drinks per occasion, rarely >14 drinks/week, ~10‑15 binge episodes) and current labs showing normal total protein, albumin, bilirubin, alkaline phosphatase, AST, ALT, platelets, and a FIB‑4 index of ~0.9, what is the likelihood that his liver is healthy and free of significant fibrosis?
What is the recommended treatment for subclavian artery stenosis?
In an 83‑year‑old man with a blood pressure of 148/88 mm Hg who had his telmisartan dose increased from 40 mg to 80 mg two weeks ago while continuing pravastatin 40 mg, what is the appropriate next step in managing his hypertension?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.